Data gathered: January 14
Alternative Data for Personalis
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 4 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 8,000 | Sign up | Sign up | Sign up |
| Employee Rating | 68 | Sign up | Sign up | Sign up |
| Google Trends | 26 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 6 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 2,455 | Sign up | Sign up | Sign up |
| Twitter Followers | 3,162 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 312 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 36 | Sign up | Sign up | Sign up |
| Linkedin Employees | 344 | Sign up | Sign up | Sign up |
About Personalis
Personalis, Inc. develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific.
| Price | $5.35 |
| Target Price | Sign up |
| Volume | 955,600 |
| Market Cap | $473M |
| Year Range | $1.17 - $6.64 |
| Dividend Yield | 0% |
| Analyst Rating | 80% buy |
| Industry | Biotechnology |
In the news
 |
Personalis’ (PSNL) Buy Rating Reiterated at HC WainwrightJanuary 11 - ETF Daily News |
|
Personalis’ (PSNL) “Buy” Rating Reiterated at Needham & Company LLCJanuary 11 - ETF Daily News |
|
Personalis (NASDAQ:PSNL) Price Target Raised to $9.00January 10 - ETF Daily News |
 |
Personalis Reports Preliminary Fourth Quarter and Full Year 2024 RevenueJanuary 9 - ETF Daily News |
|
Barclays PLC Boosts Holdings in Personalis, Inc. (NASDAQ:PSNL)January 5 - ETF Daily News |
|
Personalis, Inc. (NASDAQ:PSNL) Stock Holdings Lowered by Stifel Financial CorpDecember 31 - ETF Daily News |
Insider Transactions View All
| Tachibana Aaron filed to sell 167,098 shares at $3.8. December 18 '24 |
| Moore Stephen Michael filed to sell 65,875 shares at $3.8. December 18 '24 |
| Chen Richard filed to sell 123,886 shares at $3.8. December 18 '24 |
| Chen Richard filed to sell 128,720 shares at $3.8. November 20 '24 |
| Moore Stephen Michael filed to sell 67,388 shares at $3.8. November 20 '24 |
Similar companies
Read more about Personalis (PSNL) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Personalis?
The Market Cap of Personalis is $473M.
What is the current stock price of Personalis?
Currently, the price of one share of Personalis stock is $5.35.
How can I analyze the PSNL stock price chart for investment decisions?
The PSNL stock price chart above provides a comprehensive visual representation of Personalis' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Personalis shares. Our platform offers an up-to-date PSNL stock price chart, along with technical data analysis and alternative data insights.
Does PSNL offer dividends to its shareholders?
As of our latest update, Personalis (PSNL) does not offer dividends to its shareholders. Investors interested in Personalis should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Personalis?
Some of the similar stocks of Personalis are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.